AAV-F in pAR-9 Citations (2)
Originally described in: Selection of an Efficient AAV Vector for Robust CNS Transgene Expression.Hanlon KS, Meltzer JC, Buzhdygan T, Cheng MJ, Sena-Esteves M, Bennett RE, Sullivan TP, Razmpour R, Gong Y, Ng C, Nammour J, Maiz D, Dujardin S, Ramirez SH, Hudry E, Maguire CA Mol Ther Methods Clin Dev. 2019 Oct 23;15:320-332. doi: 10.1016/j.omtm.2019.10.007. eCollection 2019 Dec 13. PubMed Journal
Articles Citing AAV-F in pAR-9
| Articles |
|---|
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy.
Alves CRR, Ha LL, Yaworski R, Sutton ER, Lazzarotto CR, Christie KA, Reilly A, Beauvais A, Doll RM, de la Cruz D, Maguire CA, Swoboda KJ, Tsai SQ, Kothary R, Kleinstiver BP.
Nat Biomed Eng. 2023 Dec 6. doi: 10.1038/s41551-023-01132-z.
PubMed
Associated Plasmids |
| Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity. Lunavat TR, Nieland L, van de Looij SM, de Reus AJEM, Couturier CP, El Farran CA, Miller TE, Lill JK, Schubel M, Xiao T, Di Ianni E, Woods EC, Sun Y, Rufino-Ramos D, van Solinge TS, Mahjoum S, Grandell E, Li M, Mangena V, Dunn GP, Jenkins RW, Mempel TR, Breakefield XO, Breyne K. Mol Ther. 2025 Nov 5;33(11):5530-5555. doi: 10.1016/j.ymthe.2025.08.028. Epub 2025 Aug 20. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.